Stay updated on Onasemnogene for SMA: Intrathecal Clinical Trial

Sign up to get notified when there's something new on the Onasemnogene for SMA: Intrathecal Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Onasemnogene for SMA: Intrathecal Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    7 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov record for the spinal muscular atrophy study is now displayed, with its study design, participant criteria, interventions, and outcome measures. It also shows that the study was terminated early and provides record history and trial documents.
    Difference
    59%
    Check dated 2026-11-09T13:22:09.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.2 to v3.8.0, while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-02T13:17:35.000Z thumbnail image
  4. Check
    21 days ago
    Change Detected
    Summary
    A banner announces an NIH website terminology transition, noting that both “Artificial Intelligence” and “Super Intelligence” may appear in NIH content.
    Difference
    1%
    Check dated 2026-10-26T13:29:53.000Z thumbnail image
  5. Check
    28 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision identifier changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-19T13:47:09.000Z thumbnail image
  6. Check
    35 days ago
    Change Detected
    Summary
    The footer revision number changes from v3.7.0 to v3.7.1 on the 403 Forbidden page.
    Difference
    0.2%
    Check dated 2026-10-12T14:28:25.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    Access to the study record is blocked by a 403 Forbidden page, replacing the expected content with an error screen. The visible header and footer indicate an access issue rather than new or updated trial information.
    Difference
    19%
    Check dated 2026-09-21T20:36:36.000Z thumbnail image

Stay in the know with updates to Onasemnogene for SMA: Intrathecal Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Onasemnogene for SMA: Intrathecal Clinical Trial page.